According to the latest public financial data of the Catalan company, in 2018, Bioiberica earned €34.2 million in 2018, more than double compared to 2017, when...
With this round, the company also plans to consolidate itself in the Spanish market with its portfolio of products, to later go international through the European...
Last March, the biopharmaceutical company Libera Bio signed a new collaboration agreement, after partnering with Immunoprecise Antibodies, a subsidiary of Talem Therapeutics, to discover multi-target antibodies...
SolidWorld's Electrospider reproduces skin and bone fragments, with the prospect of creating organs for transplantation in the future. The most immediate application is for testing new...
In 2022, Durcal reached an average sale of 500 telecare watches per month, with peaks of up to a thousand monthly sales. Now, the company will...
Novartis has stated that it is focused on five therapeutic areas, including cardiovascular, immunology, and neuroscience. By markets, the company has detailed that it plans to...
The European pharmaceutical sector is on the rise. EU pharmaceutical exports were led by Germany and Belgium. By contrast, the largest importers were Belgium (€21 billion), followed...
Throughout 2023-2024, Heuristik has the objective of opening a financing round of €5 million, which will allow the Spanish company to continue growing in the European...
Amelia Virtual Care offers virtual reality software for mental health professionals with more than 140 virtual environments, providing clinicians with access to exposure tools and systematic...
In addition to the drug against brain tumors, Laminar has two other drugs licensed in phase two: one, developed together with Ability Pharma, against pancreatic cancer,...